Physician

Anna M Magee, MD

According to 2025 Medicare claims, Anna Magee, MD (NPI: 1962466334) practices dermatology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is CHARLOTTESVILLE DERMATOLOGY (NPI: 1316016470; TIN: 541827389) and primary practice location at 22911-8835.

Magee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,258 traditional Medicare patients, billed 7,934 HCPCS/CPT codes, and received $373,435 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 888 prescription claims across 481 beneficiaries totaling $208,076 in drug costs, led by Otezla (Apremilast). Open Payments data shows 18 records totaling $6,120. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $165,231 to $208,076. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,585	8,565	$392,434
2016	1,609	9,456	$394,372
2017	1,735	9,993	$392,104
2018	1,787	8,424	$328,383
2019	1,926	8,707	$380,228
2020	1,876	8,691	$392,785
2021	2,158	9,844	$481,003
2022	1,942	7,863	$395,295
2023	2,301	8,230	$414,175
2024	2,258	7,934	$373,435

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	318	639	$165,231
2016	303	601	$127,166
2017	328	610	$61,958
2018	333	655	$38,889
2019	314	599	$32,975
2020	368	720	$56,933
2021	442	817	$50,482
2022	452	813	$201,709
2023	506	881	$143,973
2024	481	888	$208,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	555	610	$77
11102	Biopsy of related skin growth, first growth	630	711	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,446	1,703	$56
17000	Destruction of precancer skin growth, 1 growth	964	1,198	$35
17003	Destruction of precancer skin growth, 2-14 growths	558	1,822	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	11	330	$53,217
Fluorouracil	Fluorouracil	131	3,390	$9,948
Clobetasol Propionate	Clobetasol Propionate	85	2,062	$3,044
Metronidazole	Metronidazole	45	1,311	$1,913
Triamcinolone Acetonide	Triamcinolone Acetonide	163	4,569	$1,380

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$6,120	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anna M. Magee, MD?

Tedicare shows public-source Medicare data for Anna M. Magee, MD (NPI 1962466334), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna M. Magee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anna M. Magee, MD?

Anna M. Magee, MD is linked to CHARLOTTESVILLE DERMATOLOGY (billing NPI 1316016470) in the available physician profile data.

Does Anna M. Magee, MD have Open Payments data?

Anna M. Magee, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.